Literature DB >> 33567623

Malignant Pleural Mesothelioma: Time Is Running Out.

Filippo Lococo1,2.   

Abstract

Malignant pleural mesothelioma (MPM) is a rare but highly malignant disease of the pleura usually related to asbestos exposure [...].

Entities:  

Year:  2021        PMID： 33567623      PMCID： PMC7914895          DOI： 10.3390/jcm10040648

Source DB:  PubMed          Journal:  J Clin Med        ISSN： 2077-0383            Impact factor:   4.241


  12 in total

Review 1.  Malignant mesothelioma.

Authors:  Bruce W S Robinson; Arthur W Musk; Richard A Lake
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

2.  Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.

Authors:  Filippo Lococo; Federica Torricelli; Loic Lang-Lazdunski; Giulia Veronesi; Ottavio Rena; Massimiliano Paci; Caterina Casadio; Simonetta Piana; Pierluigi Novellis; Teresa Severina Di Stefano; Alessia Ciarrocchi; Andrea Billè
Journal:  J Thorac Cardiovasc Surg       Date:  2019-09-09       Impact factor: 5.209

3.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

4.  Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma.

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Péchoux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Eur Respir J       Date:  2009-08-28       Impact factor: 16.671

5.  Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas.

Authors:  Robin Guo; Mariel DuBoff; Gowtham Jayakumaran; Mark G Kris; Marc Ladanyi; Mark E Robson; Diana Mandelker; Marjorie G Zauderer
Journal:  J Thorac Oncol       Date:  2019-12-28       Impact factor: 15.609

6.  Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.

Authors:  Edward J A Harris; Steven Kao; Brian McCaughan; Takashi Nakano; Nobuyuki Kondo; Rebecca Hyland; Anna K Nowak; Nicholas H de Klerk; Fraser J H Brims
Journal:  J Thorac Oncol       Date:  2018-10-24       Impact factor: 15.609

7.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316

Review 8.  Prognostication and monitoring of mesothelioma using biomarkers: a systematic review.

Authors:  David T Arnold; Duneesha De Fonseka; Fergus W Hamilton; Najib M Rahman; Nick A Maskell
Journal:  Br J Cancer       Date:  2017-02-07       Impact factor: 7.640

Review 9.  Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.

Authors:  Bhairavi Tolani; Luis A Acevedo; Ngoc T Hoang; Biao He
Journal:  Int J Mol Sci       Date:  2018-01-13       Impact factor: 5.923

10.  Burden of Mesothelioma Deaths by National Income Category: Current Status and Future Implications.

Authors:  Odgerel Chimed-Ochir; Diana Arachi; Tim Driscoll; Ro-Ting Lin; Jukka Takala; Ken Takahashi
Journal:  Int J Environ Res Public Health       Date:  2020-09-21       Impact factor: 3.390
View more
  2 in total

Review 1.  The Prognostic Value of 18F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review.

Authors:  Silvia Taralli; Romina Grazia Giancipoli; Carmelo Caldarella; Valentina Scolozzi; Sara Ricciardi; Giuseppe Cardillo; Maria Lucia Calcagni
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

2.  Single-Center 20-Year Experience in Surgical Treatment of Malignant Pleural Mesothelioma.

Authors:  Giuseppe Mangiameli; Edoardo Bottoni; Umberto Cariboni; Giorgio Maria Ferraroli; Emanuela Morenghi; Veronica Maria Giudici; Emanuele Voulaz; Marco Alloisio; Alberto Testori
Journal:  J Clin Med       Date:  2022-08-03       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.